The Gallo Center is evaluated annually by a
Scientific Advisory Board of international leaders in
biomedical research. All are members of the National
Academy of Sciences. The SAB is responsible for
assessing the progress of the research in relation to
the overall goals of the Center, making recommendations
for future research directions, and providing a
comprehensive review of the activities of the Center to
the President of the Board of Directors.
Current board members are:
Stanley Prusiner, MD, Chairman, Director, Institute
for Neurodegenerative Diseases, and Professor of
Neurology and Biochemistry, University of California,
San Francisco (Nobel Laureate);
Guoping Feng, PhD, McGovern Institute for Brain
Research at MIT, and faculty member in the Department
of Brain and Cognitive Sciences at MIT;
Eric R. Kandel, MD, University Professor of
Physiology and Cellular Biophysics, Biochemistry and
Molecular Biophysics, and Psychiatry, Columbia
University, College of Physicians & Surgeons,
Psychiatric Institute (Nobel Laureate);
George F. Koob, PhD, Professor and Chair of the
Committee on the Neurobiology of Addictive Disorders at
The Scripps Research Institute, Adjunct Professor in
the Departments of Psychology and Psychiatry, and
Adjunct Professor in the Skaggs School of Pharmacy and
Pharmaceutical Sciences at UC San Diego;
Richard P. Lifton, MD, PhD, Sterling Professor of
Genetics, Professor of Medicine, and Professor of
Molecular Biophysics and Biochemistry, Yale University
School of Medicine;
Thomas C. Südhof, MD, Howard Hughes Medical Institute,
Director of the Center for Basic Neuroscience,
Professor in the Molecular and Cellular Physiology
Department at the Stanford School of Medicine, and
member of the Institute of Medicine (2008), and the
National Academy of Sciences (2002). |